Triphala
supporting digestive regularity
Triphala is an Ayurvedic herbal blend of three fruits, traditionally used to support digestive health and general well-being, though scientific evidence is still developing.
Quick answer
What it is: Triphala is an Ayurvedic herbal formulation consisting of three fruits: Amalaki (Emblica officinalis), Bibhitaki (Terminalia bellirica), and Haritaki (Terminalia chebula).
May support:Chronic Constipation, Constipation
Evidence:Evidence · Grade B
Evidence Summary
The current evidence grade for Triphala is based primarily on traditional use and anecdotal reports. While some preliminary in vitro and animal studies exist, there is a significant lack of high-quality human clinical trials to substantiate many of its purported health benefits. Therefore, claims regarding efficacy are largely theoretical or derived from traditional knowledge rather than robust scientific validation.
Last reviewed · Jun 2026
Have you tried Triphala?
Vote in 5 seconds. Add details if you want.
Your experience for Chronic Constipation:
Commonly Combined With
Other remedies frequently used alongside this one — from curated relationships, community reports, and shared protocols.
Community signal breakdown
Where this remedy is being discussed across the web and community.
People Like Me insights
As more members share outcomes, RemedyAtlas will show which remedies helped people with similar conditions, symptoms, goals, and lab patterns.
Community Discussions
What people say about Triphala
Latest News
Latest news on Triphala
Health Videos
Health videos on Triphala
Why It Works
How it works in more detail
How to use
Always consult a qualified clinician.Editorial guidance
- Blood thinners (anticoagulants)
- Diabetes medications (may lower blood sugar)
- Blood pressure medications (may lower blood pressure)
- Pregnant
- Breastfeeding
- Children
- Severe diarrhea
- Crohn's disease
- Ulcerative colitis
Community tips
No community tips yet — be the first to share what worked for you.
Suggested dosage
General guidance — discuss specifics with a clinician.
Active medicinal compounds
Traditional use
Safety
Safety warnings
Avoid if
- Pregnant
- Breastfeeding
- Children
- Severe diarrhea
- Crohn's disease
- Ulcerative colitis
Medication interactions
- Blood thinners (anticoagulants)
- Diabetes medications (may lower blood sugar)
- Blood pressure medications (may lower blood pressure)
Reported side effects
- Diarrhea
- Abdominal cramping
- Gas
- Bloating
General guidance — discuss specifics with a clinician.
Evidence ecosystem
Scientific literature, clinical guidance, government sources, ongoing research, traditional use, and lived experience — grouped by source type and quality.
Overall grade (B)
The current evidence grade for Triphala is based primarily on traditional use and anecdotal reports. While some preliminary in vitro and animal studies exist, there is a significant lack of high-quality human clinical trials to substantiate many of its purported health benefits. Therefore, claims regarding efficacy are largely theoretical or derived from traditional knowledge rather than robust scientific validation.
Systematic Reviews(1)
Structured reviews of the full body of evidence (incl. Cochrane).
Nutrition, Obesity, and Seborrheic Dermatitis: Systematic Review.
Woolhiser E, Keime N, Patel A, Weber I, Adelman M, Dellavalle RP · JMIR dermatology · 2024 · n=906
Pathogenesis of seborrheic dermatitis involves lipid secretion by sebaceous glands, Malassezia colonization, and an inflammatory response with skin barrier disruption. Each of these pathways could be modulated by diet, obesity, and nutritional supplements. Current treatment options provide only temporary control of the condition; thus, it is essential to recognize modifiable lifestyle factors that may play a role in determining disease severity. This study aimed to summarize published evidence on diet, nutritional supplements, alcohol, obesity, and micronutrients in patients with seborrheic dermatitis and to provide useful insights into areas of further research. A literature search of Scopus, PubMed, and MEDLINE (Ovid interface) for English language papers published between 1993 and 2023 was conducted on April 16, 2023. Case-control studies, cohort studies, and randomized controlled trials with 5 or more subjects conducted on adult participants (>14 years) were included, case rep
Systematic ReviewPubMedVery High Quality
Limitations: A major limitation is the absence of well-designed, placebo-controlled human clinical trials. Most existing studies are small, short-term, or conducted in animal models, which may not translate directly to human effects. There is also variability in Triphala formulations, making it difficult to compare results across studies. The lack of standardized dosages and outcome measures further limits the strength of current evidence.
This page is educational. Statements use phrases like "may support" and "has been studied for"because no remedy here is approved to cure, treat, or reverse any condition. Discussion happens on the ailment pages — community statistics here are derived from those reports. Always consult a qualified clinician.
Tried Triphala?
Help others see what actually works.
Tried Triphala?
Real-world results help others choose what's worth trying.